Ignite Creation Date:
2024-05-06 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03611738
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2018-07-27
Brief Title:
Ceritinib Plus Docetaxel in ALK-Negative EGFR WT Advanced NSCLC
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| EGFR Negative Non-Small Cell Lung Cancer |
| Non-small Cell Lung Cancer |
| Lung Cancer |
| Non-small Cell Lung Cancer Metastatic |
| Non-small Cell Lung Cancer Stage IIIB |
| Stage IV Non-small Cell Lung Cancer |